Moderna CEO Sees New Flu Shot as Chance to Promote mRNA Technology
2026-06-25 21:09:38
Moderna Inc. Chief Executive Officer Stephane Bancel said the pending launch of the company’s planned flu vaccine is an opportunity to start a public conversation about how mRNA technology could offer better protection against seasonal influenza, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Polymarket称第三方供应商被攻破
